Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 2068-2074

  Larsson, Hillevi ^a   Ahren B O ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROINSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PRIORITY JOURNAL;

EID: 0033305627     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.6.2068     Document Type: Article

References (50)

1. Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood
2. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet β-cell dysfunction?
3. Banting lecture 1990. β-cells in type II diabetes mellitus
4. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
5. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus
6. Disproportionately elevated pro-insulin in Pima Indians with noninsulin-dependent diabetes mellitus
7. Age-related alteration of pancreatic β-cell function
8. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM
9. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes
10. Disproportionately elevated proinsulin levels reflect the degree of impaired B celt secretory capacity in patients with noninsulin-dependent diabetes mellitus
11. Proinsulin as a marker for the development of NIDDM in Japanese-American men
12. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: The Mexico City Diabetes Study
13. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects
14. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: The Hoorn Study
15. New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors
16. Circulating proinsulinlike molecules
17. The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects
18. Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects
19. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance
20. Hyperproinsulinemia in impaired glucose tolerance
21. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM
22. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome
23. Hyperpro-insulinemia of type II diabetes is not present before the development of hyperglycemia
24. Hyperinsulinemia in nondiabetic Asian subjects using specific assays for insulin, intact proinsulin, and des-31,32-proinsulin
25. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers
26. Specific insulin and proinsulin concentrations in nondiabetic South Indians
27. Metabolism of endogenous proinsulin and insulin in man
28. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance
29. Islet dysfunction in obese women with impaired glucose tolerance
30. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function
31. Glucose clamp technique: A method for quantifying insulin secretion and resistance
32. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
33. Glucose-dependent arginine stimulation test for characterization of islet function: Studies on reproducibility and priming effect of arginine
34. Potentiation of insulin release by glucose in man
35. Time and dose dependencies for priming effect of glucose on insulin
36. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance
37. Proinsulin, C peptide, and insulin in normal subjects during an 8-h hyperglycemic clamp
38. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans
39. Measurement of insulin and proinsulin
40. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus
41. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance
42. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects
43. Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans
44. Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin
45. Extraction of insulin by liver
46. Hepatic removal of insulin in normal man: Dose response to endogenous insulin secretion
47. Quantitative study of insulin secretion and clearance in normal and obese subjects
48. C-Peptide